LAVAL, Quebec, Jan. 3, 2018 /CNW/ -- Valeant
Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX)
("Valeant") today announced that Joseph C.
Papa, chairman and chief executive officer, is scheduled to
present at the 36th Annual J.P. Morgan Healthcare
Conference in San Francisco on
Wednesday, Jan. 10, 2018, at
10:30 a.m. PST (1:30 p.m. EST).
A live webcast and audio archive of the event will be available
on the Investor Relations page of the Valeant web site at:
http://ir.valeant.com/events-and-presentations/2018.
About Valeant
Valeant Pharmaceuticals International,
Inc. (NYSE/TSX:VRX) is a multinational specialty pharmaceutical
company that develops, manufactures and markets a broad range of
pharmaceutical products primarily in the areas of dermatology,
gastrointestinal disorders, eye health, neurology and branded
generics. More information about Valeant can be found at
www.valeant.com.
|
Investor
Contact:
|
Media
Contact:
|
|
Arthur
Shannon
|
Lainie
Keller
|
|
arthur.shannon@valeant.com
|
lainie.keller@valeant.com
|
|
(514)
856-3855
|
(908)
927-0617
|
|
(877) 281-6642 (toll
free)
|
|
View original content with
multimedia:http://www.prnewswire.com/news-releases/valeant-to-present-at-the-36th-annual-jp-morgan-healthcare-conference-300574997.html
SOURCE Valeant Pharmaceuticals International, Inc.